India can replace China as the world’s preferred source of pharmaceutical ingredients. It’s gain from this opportunity in the API business would depend on how swiftly the policy makers in India respond to it. While India is an exporter of certain APIs, it is quite dependent on China for many others.
Pharmaceutical Industry and Public Policy in Post-reform India, Routledge, 2016.
Investment Facilitation Agreement in WTO: Where is it headed?, in Yearbook on International Investment Law & Policy 2017, Oxford University Press, 2019.
Outward FDI from India: Review of Policy and Emerging Trends, Working Paper ISID, 2019.
Office Address :
Dr. Reji K. Joseph
Institute for Studies in Industrial Development
Vasant Kunj Institutional Area Phase-II
New Delhi – 110070, India
Professional Links :
© 2020 Reji K. Joseph | All Rights Reserved | Designed By Cdigimedia Technologies